Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan · Delayed Price · Currency is TWD

16.95

-0.10 (-0.59%)

At close: Aug 28, 2026

Daiken Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	13,654	14,540	10,860	-	-
Market Cap Growth	-32.67%	33.88%	-	-	-
Enterprise Value	8,510	9,496	9,874	-	-
Last Close Price	16.95	17.11	16.53	-	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	30.78	43.03	101.90	-	-
Forward PE	-	34.13	-	-	-
PS Ratio	6.25	7.67	7.97	-	-
PB Ratio	2.80	2.67	8.31	-	-
P/TBV Ratio	2.80	2.67	8.33	-	-
P/FCF Ratio	52.14	53.42	215.06	-	-
P/OCF Ratio	52.00	53.34	209.86	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
EV/Sales Ratio	3.89	5.01	7.25	-	-
EV/EBITDA Ratio	21.04	32.17	64.48	-	-
EV/EBIT Ratio	21.60	32.95	66.31	-	-
EV/FCF Ratio	32.49	34.89	195.53	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	0.02	0.02	0.00	1.12	0.60
Debt / EBITDA Ratio	0.29	0.40	0.01	1.35	1.21
Debt / FCF Ratio	0.45	0.44	0.05	2.63	3.27
Net Debt / Equity Ratio	-1.06	-0.39	-0.87	-0.04	-0.47
Net Debt / EBITDA Ratio	-12.83	-7.17	-7.43	-0.05	-0.96
Net Debt / FCF Ratio	-19.64	-7.78	-22.52	-0.10	-2.59
Asset Turnover	0.56	0.51	1.19	1.87	-
Inventory Turnover	1.95	2.08	1.99	1.71	-
Quick Ratio	4.29	5.33	5.36	0.80	1.23
Current Ratio	4.75	13.12	6.56	1.64	2.17
Return on Equity (ROE)	14.21%	10.01%	13.71%	67.55%	-
Return on Assets (ROA)	6.26%	4.83%	8.15%	20.01%	-
Return on Invested Capital (ROIC)	-	13.35%	55.95%	94.00%	77.31%
Return on Capital Employed (ROCE)	8.00%	5.30%	11.40%	68.80%	38.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Earnings Yield	3.11%	2.32%	0.98%	-	-
FCF Yield	1.92%	1.87%	0.46%	-	-
Dividend Yield	4.14%	4.08%	2.44%	-	-
Payout Ratio	128.54%	174.40%	2.89%	87.59%	-
Buyback Yield / Dilution	-28.50%	-52.12%	-95.20%	-44.34%	-
Total Shareholder Return	-24.36%	-48.03%	-92.75%	-44.34%	-